Thermo Fisher’s Q2 Revenues Rise on Better Pharma Spending, Analytical Instrument Demand | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Thermo Fisher Scientific officials last week said that strong customer end markets for its analytical instruments, particularly in biotech, helped the firm achieve 9 percent revenue growth in the second quarter. The firm also announced that it had acquired an Indian chemical supplier as its footprint in the region continues to grow.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.